GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Escalon Medical Corp (OTCPK:ESMC) » Definitions » Cash Conversion Cycle

Escalon Medical (Escalon Medical) Cash Conversion Cycle : 77.40 (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is Escalon Medical Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Escalon Medical's Days Sales Outstanding for the three months ended in Dec. 2023 was 54.39.
Escalon Medical's Days Inventory for the three months ended in Dec. 2023 was 83.05.
Escalon Medical's Days Payable for the three months ended in Dec. 2023 was 60.04.
Therefore, Escalon Medical's Cash Conversion Cycle (CCC) for the three months ended in Dec. 2023 was 77.40.


Escalon Medical Cash Conversion Cycle Historical Data

The historical data trend for Escalon Medical's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Escalon Medical Cash Conversion Cycle Chart

Escalon Medical Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 146.16 133.04 82.17 71.89 74.43

Escalon Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.25 70.20 76.58 70.50 77.40

Competitive Comparison of Escalon Medical's Cash Conversion Cycle

For the Medical Devices subindustry, Escalon Medical's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Escalon Medical's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Escalon Medical's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Escalon Medical's Cash Conversion Cycle falls into.



Escalon Medical Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Escalon Medical's Cash Conversion Cycle for the fiscal year that ended in Jun. 2023 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=47.89+86.96-60.42
=74.43

Escalon Medical's Cash Conversion Cycle for the quarter that ended in Dec. 2023 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=54.39+83.05-60.04
=77.40

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Escalon Medical  (OTCPK:ESMC) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Escalon Medical Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Escalon Medical's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Escalon Medical (Escalon Medical) Business Description

Traded in Other Exchanges
N/A
Address
435 Devon Park Drive, Suite 824, Wayne, PA, USA, 19087
Escalon Medical Corp operates in the healthcare market specializing in the development, manufacture, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology. Its products are A-Scans, B-Scans, UBM, Pachymeters, Color/Fluorescein Angiography Digital Imaging Systems, Ispan Intraocular Gases, Surgical Packs, Viscous Fluid Transfer Systems, and AXIS Image Management. Substantial revenue is generated from the domestic sales of products.
Executives
David James Jacovini director 120 PINE STREET, PHILADELPHIA PA 19106
John Dogum director 1818 MARKET STREET, 35TH FLOOR, PHILADELPHIA PA 19103
Richard J Depiano director 435 DEVON PARK DRIVE, SUITE 100, WAYNE PA 19087
Lisa A Napolitano director 351 EAST CONESTOGA ROAD, WAYNE PA 19087
C Sean Closkey director 1700 MARKET STREET, 19TH FLOOR, PHILADELPHIA PA 19103
C Todd Trusk director 1410 RUSSELL ROAD, SUITE 100, WAYNE PA 19301
Robert Michael O'connor officer: Chief Financial Officer 53 SORREL RUN, MT. LAUREL NJ 08054
Anthony J Coppola director 1 NORTH NEW YORK ROAD, SMITHVILLE NJ 08205
Federman Jay L Md director 501 N. ESSEX AVENUE, NARBERTH PA 19072
Kwan William L G director 351 EAST CONESTOGA ROAD, WAYNE PA 19087
Mark Wallace officer: Chief Operating Officer 565 E SWEDESFORD ROAD, STE 200, WAYNE PA 19087
Fred G Choate director 601 DELSEA DRIVE, WASHINGTON TOWNSHIP NJ 08080
Depiano Richard J Jr officer: President 575 E. SWEDESFORD ROAD, SUITE 100, WAYNE PA 19087
Berkowitz David officer: Principal Accounting Officer 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087
Mark H Karsch officer: CFO 565 EAST SWEDESFORD ROAD, SUITE 200, WAYNE PA 19087

Escalon Medical (Escalon Medical) Headlines